Chevy Chase Trust’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,235
Closed -$298K 673
2021
Q3
$298K Sell
7,235
-9,153
-56% -$502K ﹤0.01% 630
2021
Q2
$928K Sell
16,388
-156,362
-91% -$5.78M ﹤0.01% 579
2021
Q1
$7.25M Sell
172,750
-1,022,658
-86% -$58.3M 0.03% 473
2020
Q4
$83.8M Sell
1,195,408
-93,350
-7% -$3.83M 0.3% 79
2020
Q3
$36.2M Buy
1,288,758
+165,274
+15% +$5.38M 0.14% 151
2020
Q2
$33.2M Buy
1,123,484
+93,368
+9% +$2.44M 0.13% 160
2020
Q1
$20.4M Buy
1,030,116
+59,159
+6% +$1.49M 0.1% 197
2019
Q4
$28.7M Buy
970,957
+34,101
+4% +$852K 0.11% 192
2019
Q3
$21.3M Buy
936,856
+76,971
+9% +$1.91M 0.09% 244
2019
Q2
$21.3M Buy
859,885
+158,145
+23% +$3.77M 0.09% 234
2019
Q1
$17.4M Buy
701,740
+181,921
+35% +$4.12M 0.07% 282
2018
Q4
$11.8M Buy
519,819
+17,680
+4% +$481K 0.06% 329
2018
Q3
$16M Buy
502,139
+53,991
+12% +$1.74M 0.07% 304
2018
Q2
$16.1M Buy
448,148
+54,850
+14% +$1.94M 0.07% 297
2018
Q1
$13M Buy
+393,298
New +$14M 0.06% 338

Other funds holding EDIT

Chevy Chase Trust's EDIT Position: Q4 2021 in Review

Chevy Chase Trust sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 7,235 shares — an estimated $298K sold.

Chevy Chase Trust first reported a position in EDIT in Q1 2018 and held it in 15 quarters. The position peaked at $83.8M in Q4 2020. 306 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Chevy Chase Trust reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Chevy Chase Trust sold 7,235 Editas Medicine shares in Q4 2021, an estimated $298K.
  • Chevy Chase Trust first reported a position in Editas Medicine in Q1 2018 and held it in 15 quarters.
  • Chevy Chase Trust's Editas Medicine position peaked at $83.8M in Q4 2020.
  • 306 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Chevy Chase Trust's 13F filing for Q4 2021, filed 31 Jan 2022.